When a biopharmaceutical facility expands, attention usually goes first to bioreactors, filling equipment, production lines and cleanroom capacity.
But another system can become a critical part of the expansion plan:
The process water system.
Higher production capacity means not only more equipment, but potentially greater and more consistent water demand.
The European Medicines Agency states that pharmaceutical water systems should be designed according to the required water quality while considering factors such as water quantity, system configuration, storage and distribution. EU GMP guidance also emphasizes designing water treatment and distribution systems to minimize risks associated with particulates, microbial contamination, pyrogens and biofilm formation.
For a growing biopharmaceutical facility, this means adding production equipment without reviewing water-generation capacity may create a future infrastructure constraint.
EPC planning should therefore consider:
Current water demand
Future production capacity
Distiller capacity
Potential expansion
Storage and distribution
Continuous operation requirements
Distillation remains an important technology for high-purity pharmaceutical water. WHO guidance describes distillation as a robust traditional approach for producing water for injection.
Hebei Guanyu provides multi-effect tubular water distillers and high-efficiency electric water distillers for pharmaceutical and industrial applications.
For biopharmaceutical EPC projects, water generation should not be treated as an afterthought.
It should be part of the expansion plan from the beginning.
